郑毅然

发布时间：2026-02-10浏览次数：16

  • 1、Cell Surface-tethered Nucleic Acid Therapeutics Program Robust and Tumor-responsive Enhancement of Adoptive Cell Therapy, Advanced Materials, Mengqian Gao, Ying Liu, Lei Zhao, Jin Chen, Wenjun Wan, Yajun Wang#, Yiran Zheng#, 37, 2419969 (2025)
  • 2、In situ therapeutic vaccines for leukemia by chemo-nanoadjuvant therapy, Journal of Controlled Release, Peng Zhang, Guanhong Cui, Tanzhen Wang, Xiaofei Zhao, Tianhui Liu#, Yiran Zheng#, Zhiyuan Zhong#, 383, 113851 (2025)
  • 3、Systemic multifunctional nanovaccines for potent personalized immunotherapy of acute myeloid leukemia, Advanced Materials,Peng Zhang，Tianzhen Wang, Guihong Cui,Ruonan Ye,Wenjun Wan,Tianhui Liu#, Yiran Zheng#, Zhiyuan Zhong#,36, 2407189 (2024)
  • 4、Chemokine-based injectable navigation system for enhancing CAR-T cell therapy against solid tumors, Advanced Functional Materials, Wenjun Wan, Wenqing Han, Jin Chen, Yangjing Li, Yiran Zheng#, 34, 2401161 (2024)
  • 5、Paravertebrally‐injected multifunctional hydrogel for sustained anti‐inflammation and pain relief in lumbar disc herniation, Advanced Healthcare Materials, Wenhao Deng, Jin Chen, Xinli Wang, Qianliang Wang, Lei Zhao, Jun Yan#, Yiran Zheng#, 13, 2401227 (2024)
  • 6、Uplifting anti-tumor immunotherapy with lymph node-targeted and ratio-controlled co-delivery of tumor cell lysate and adjuvant, Advanced Healthcare Materials, Guihong Cui, Yinping Sun, Liping Qu, Yiran Zheng#, Zhiyuan Zhong#, 13, 2303690 (2024)
  • 7、Roadmap to next-generation cancer vaccines, Journal of Controlled Release, Yiran Zheng#, Zhiyuan Zhong#, 347, 308-313 (2022)
  • 8、Enhancing adoptive T cell therapy for solid tumor with cell-surface anchored immune checkpoint Inhibitor nanogels, Nanomedicine:NBM, Xingye Chen, Mengqian Gao, Shan An, Lei Zhao, Wenqing Han, Wenjun Wan, Jin Chen, Siqi Ma, Wenhua Cai, Yanni Cao, Dawei Ding, Yi Yan Yang, Lifang Cheng#, Yiran Zheng#, 45,102591 (2022)
  • 9、Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy, Advanced Healthcare Materials, M. He, T. Yang, Y. Wang, M. Wang, X. Chen, Dawei Ding#, Yiran Zheng#, Huabing Chen#, 10(9): 2002104 (2021)
  • 10、Cationic polymer synergizing with chemotherapeutics and re-purposing antibiotics against cancer cells, Biomaterials Science, Yiran Zheng#, J. Kng, C. Yang, J. L. Hedrick,, Yi Yan Yang#, 9, 2174-2182 (2021)
  • 11、Enhancing T-cell therapy through TCR signaling-responsive nanoparticle drug delivery, Nature Biotechnology, Li Tang, Yiran Zheng (co-first author), M. Melo, L. Mabardi, A. P. Castano, Y.Q. Xie, N. Li, S. B. Kudchodkar, H. C. Wong, E. K. Jeng, M. V. Maus, Darrell Irvine#, 36 (8), 707 (2018)
  • 12、Enhancing adoptive cell therapy of cancer through targeted delivery of small-molecule immunomodulators to internalizing or non-internalizing receptors, ACS Nano, Yiran Zheng, Li Tang, L. Mabardi, S. Kumari, Darrell Irvine#, 11(3):3089-3100 (2017)
  • 13、In vivo Targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes, Journal of Controlled Release, Yiran Zheng, M. T. Stephan, S. A. Gai, W. Abraham, A. Shearer, Darrell J. Irvine#, 172(2):426-35 (2013)
  • 14、Structure-based programming of lymph-node targeting in molecular vaccines, Nature, H. Liu, K. Moynihan, Y. Zheng, G. Szeto, A. Li, B. Huang, D. Egeren, C. Park, Darrell Irvine#, 507(7493): 519–522 (2014)